Participated · Series A · Apr 2026

KaBoom!!!! operates a customer-facing platform and serves enterprise customers. The company plans to use proceeds from its recently announced Series A to expand platform functionality and bolster its enterprise offerings. It also intends to scale its team to support that growth. Financially, KaBoom!!!! has secured $24 million in Series A funding led by Insight Partners. The company has stated the funding will help deliver greater value to its customers and support forthcoming product and organizational developments.

Participated · Series A · Mar 2026

Condor’s AI-powered Financial Intelligence Platform consolidates clinical, operational, and financial data using proprietary clinical and financial ontologies to map relationships between protocols, site activity, vendor contracts, and accounting rules. The platform includes three core modules—Connect (data integration), Compass (forecasting and scenario modeling), and Copilot (automation of accruals, reconciliations, and month-end close). Condor manages over $19 billion in R&D spend and counts customers such as Acadia Pharmaceuticals, Alumis Therapeutics, BridgeBio Pharma, and Madrigal Pharmaceuticals. Customers report better than 90% forecast accuracy, 70% faster month-end close, and an average of 30% budget savings. The company plans to expand enterprise capabilities and scale engineering, product, design, sales, and customer success teams using proceeds from its Series A. Condor was founded by Jennifer Kyle and is headquartered in San Diego.

Led · Series B · Aug 2024

Founded in 2017 in Fort Collins, Colorado, Tilt (Career Allies, Inc.) is building a cloud-based platform that guides employers and employees through every stage of a leave of absence. The software delivers a research-backed, inclusive workflow that helps companies retain talent, support managers, and ensure respectful transitions during parental or other leaves. By automating complex compliance tasks and offering employee-centric support tools, Tilt aims to reduce turnover and attract new generations of workers. The company positions its Talent in Leave Technology (TiLT) as an easy-to-use SaaS solution that replaces fragmented, manual processes. Proceeds from its new Series A funding will be directed toward further engineering and product enhancements that “turn current leave management systems on their heads” and deepen the platform’s humanized support features. No operating metrics such as revenue or user numbers were disclosed in the articles.

Participated · Series B · Mar 2022

Swiftly builds shopping technology that taps online shopping experiences to make brick-and-mortar stores more engaging and easy, and it provides analytics and advertising for retailers. Earlier reporting said Swiftly was used by hundreds of consumer brands across nearly 10,000 store locations, accounting for more than $30 billion in gross merchandise volume. The company is targeting roughly 200,000 brick-and-mortar food retailers in the U.S. and aims to democratize tools deployed by the largest retailers. Company leadership said the new capital will enable retailers to have the digital platforms necessary to service and gain customers and to capture retail media revenues. Swiftly has raised two $100 million rounds in the past six months and entered unicorn territory with a $1 billion valuation. Swiftly builds technology tools — mobile capabilities, analytics and advertising — that help brick-and-mortar retailers engage shoppers digitally and compete with e-commerce. The company has focused on grocery but plans to expand into verticals such as beauty, home improvement and sporting goods. Since its seed round in 2018 Swiftly has more than doubled in size and added senior leadership including a CRO, CFO and several VPs. Its platform is used by hundreds of consumer brands across nearly 10,000 store locations and accounts for more than $30 billion in gross merchandise volume. Prior to its latest raise the company had raised $15 million; Swiftly will invest new capital in engineering, sales and marketing, and technology infrastructure as it scales. CEO Henry Kim said the company aims to deploy across the next million retail stores worldwide. Swiftly builds a supermarket operating system that helps grocery stores and retailers compete with major players like Amazon and Walmart. The product includes an app with fast checkout, shopping lists, coupons, and provides grocery stores with insights around loyalty and customer preferences. The operating system is already running in grocery stores in Georgia and California, and the company plans to roll the product out nationwide. One of Swiftly’s largest customers is Zion Market. The company’s founders include Henry Kim, Sean Turner, Karen Ho, and Daniel Kim, who previously worked at Symphony Commerce. Swiftly relocated from Palo Alto to Seattle to hire engineers from large tech companies and to build a scalable product; it recently raised $15.6 million in funding to support its growth.

Participated · Series C · Jun 2021

Kindbody operates a network of ownership-operated and partner fertility clinics and a technology platform that delivers employer-sponsored family-building benefits across the full reproductive spectrum from preconception through menopause. The company integrates virtual and in-person care and manages services including fertility assessment, preservation, genetic testing, IVF, donor and surrogacy services, adoption support, and mental and emotional care. Kindbody says its direct-provider model saves employers 25%–30% by contracting to deliver comprehensive care, improving cost, experience, and outcomes. It serves 112 large employers covering more than 2.4 million lives and treats patients at 32 signature clinics plus hundreds of partner clinics. Leadership has signaled plans to use strategic investments to expand into geographies with the greatest demand for high-quality fertility care. Kindbody operates a technology-driven network of fertility clinics and provides employer-contracted family-building benefits, delivering both virtual and in-person care. Led by founder and chairwoman Gina Bartasi, the company owns and operates 31 clinics nationwide and contracts directly with employers. In 2022 the company made three strategic acquisitions—including Vios Fertility Institute, a genomics company adding genetic testing and carrier screening, and a gestational surrogacy agency—to expand its end-to-end care model. Kindbody plans to open ten new clinics in 2023 in underserved U.S. markets with the greatest demand for affordable, high-quality fertility healthcare. The company raised $100M in the latest funding round, bringing its valuation to $1.8 billion and total equity and debt funding to more than $290M. It intends to use the proceeds to add new clinics in underserved U.S. markets and to invest in operations to further enhance its care model. Kindbody is a New York City–based fertility and family-building company founded in 2018 that provides fertility, gynecology and family-building services. It operates over 300 locations, including signature and partner clinics as well as mobile clinics. The company’s suite covers egg freezing, IVF, IUI, egg and sperm donation, adoption and surrogacy, maternity care, ongoing gynecology and holistic wellness, plus local and virtual events supporting community education and LGBTQ+ inclusivity. Kindbody also offers a fertility benefit solution to employers. Its proprietary patient portal and electronic medical record platform enable machine-learning to reduce variable decision making among providers and improve outcomes. In June 2021 the company raised $62M in a Series C to accelerate growth, enhance its proprietary technology, and expand access to partner, signature, and mobile clinics. The company is led by CEO Gina Bartasi and a senior leadership team including Annbeth Eschbach, Dr. Lynn Westphal, Meredith Whitney, Cindy Gentry, Shilpa Patel, Dr. Fahimeh Sasan and Richard Forsythe. Kindbody provides end-to-end fertility, gynecology, and family-building care, serving patients from preconception through postpartum. Its services include fertility treatments such as IVF and egg freezing, gynecology, wellness, and LGBTQ+ services. The company operates as both a provider and a network solution, working with employers as a full-service benefits solution and directly with patients. Kindbody leverages proprietary technology to deliver a seamless member experience and data-driven results across its 180+ Kindbody and Center of Excellence (COE) locations. The clinical leadership includes CMO Dr. Lynn Westphal and Founding Ob/Gyn Dr. Fahimeh Sasan, and the company is led by Founder and CEO Gina Bartasi. Following the Series B, Kindbody plans to expand its national footprint and build an international presence through brick-and-mortar locations and a COE network of partner clinics. Kindbody operates pop-up and brick‑and‑mortar fertility clinics and a mobile van that provides free AMH blood tests and directs patients to fuller assessments and services. Its core paid service is egg freezing, priced at $6,000 per cycle (excluding medication costs), below market averages; it also offers IVF and IUI services priced in line with competitors. The company leverages millennial‑focused branding and social media to drive attendance at pop‑ups and mobile clinics. Kindbody plans a “fertility bus” offering full on‑site assessments (AMH test, pelvic ultrasound, specialist consultation) and will use the bus to visit NYC and San Francisco, targeting large employers. With the latest funding, Kindbody will open a second Manhattan clinic, its first permanent San Francisco clinic, and is closing an acquisition for a Los Angeles clinic. The company says it will expand services to include mental health, nutrition and gynecological care; it has raised $22 million to date.